Skip to main content
logo
Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India flag India · Delayed Price · Currency is INR
1,310.00
+18.70 (1.45%)
Jul 4, 2025, 3:30 PM IST

Dr. Reddy's Laboratories Revenue

In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B INR with 16.61% growth. Dr. Reddy's Laboratories had revenue of 85.06B in the quarter ending March 31, 2025, with 20.09% growth.

Revenue
325.54B
Revenue Growth
+16.61%
P/S Ratio
3.34
Revenue / Employee
11.71M
Employees
27,811
Market Cap
1,086.01B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025325.54B46.37B16.61%
Mar 31, 2024279.16B33.29B13.54%
Mar 31, 2023245.88B31.49B14.69%
Mar 31, 2022214.39B24.67B13.00%
Mar 31, 2021189.72B15.12B8.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 525.78B
Divi's Laboratories 93.60B
Cipla 272.67B
Apollo Hospitals Enterprise 217.94B
Zydus Lifesciences 232.42B
Mankind Pharma 122.07B
Aurobindo Pharma 317.24B
Fortis Healthcare 77.83B
Revenue Rankings

Dr. Reddy's Laboratories News

More News